Overview

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This is a Phase 2 open-label extension study to evaluate the effects of ANAVEX2-73 on safety and efficacy of daily treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Anavex Life Sciences Corp.
Collaborators:
Anavex Australia Pty Ltd.
Anavex Germany GmbH